• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Influence of Frailty Syndrome and Dementia on the Convenience and Satisfaction with Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation.衰弱综合征和痴呆对老年房颤患者口服抗凝治疗便利性和满意度的影响。
Int J Environ Res Public Health. 2022 Apr 28;19(9):5355. doi: 10.3390/ijerph19095355.
2
Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation.老年人非瓣膜性心房颤动患者的衰弱、认知障碍和抗凝治疗。
J Am Geriatr Soc. 2020 Dec;68(12):2778-2786. doi: 10.1111/jgs.16756. Epub 2020 Aug 11.
3
Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial.经导管主动脉瓣置换术后接受依度沙班或维生素K拮抗剂治疗的心房颤动患者的治疗满意度和便利性:ENVISAGE-TAVI AF试验的事后分析
Am J Cardiol. 2023 Dec 15;209:212-219. doi: 10.1016/j.amjcard.2023.09.091. Epub 2023 Oct 14.
4
Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.老年人房颤患者的生理、认知和心理社会状况与抗凝满意度的关系:SAGE-AF 研究。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2508-2515. doi: 10.1111/jce.14176. Epub 2019 Sep 25.
5
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.在 1 年随访期间,接受稳定维生素 K 拮抗剂治疗或换用非维生素 K 拮抗剂口服抗凝剂的心房颤动患者的生活质量和患者满意度:AF 登记处的 PREFER 子研究。
Arch Cardiovasc Dis. 2018 Feb;111(2):74-84. doi: 10.1016/j.acvd.2017.04.007. Epub 2017 Sep 21.
6
Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study.用于房颤卒中预防的达比加群与维生素 K 拮抗剂的患者感知和治疗便利性:长期抗凝治疗经验真实世界评估(RE-LATE)研究。
Open Heart. 2021 Dec;8(2). doi: 10.1136/openhrt-2021-001745.
7
Quality of Life and Frailty Syndrome in Patients with Atrial Fibrillation.生活质量与心房颤动患者的衰弱综合征。
Clin Interv Aging. 2020 May 29;15:783-795. doi: 10.2147/CIA.S248170. eCollection 2020.
8
Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.衰弱患者心房颤动抗凝治疗的有效性和安全性。
Stroke. 2022 Jun;53(6):1873-1882. doi: 10.1161/STROKEAHA.121.036757. Epub 2022 Feb 3.
9
Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatran.对从长期维生素K拮抗剂治疗转换为达比加群治疗的房颤患者的感知、便利性及抗凝治疗满意度的真实世界评估
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001343.
10
Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study).患者对预防中风的抗凝治疗的认知(共鸣研究)。
Open Heart. 2020 Mar 24;7(1):e001202. doi: 10.1136/openhrt-2019-001202. eCollection 2020.

引用本文的文献

1
Anxiety and Depressive Symptoms, Frailty and Quality of Life in Atrial Fibrillation.心房颤动患者的焦虑抑郁症状、衰弱和生活质量。
Int J Environ Res Public Health. 2023 Jan 6;20(2):1066. doi: 10.3390/ijerph20021066.

本文引用的文献

1
Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines.心房颤动:2020 ESC 指南的老年医学视角。
Eur Geriatr Med. 2022 Feb;13(1):5-18. doi: 10.1007/s41999-021-00537-w. Epub 2021 Nov 2.
2
Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants.退伍军人对心房颤动抗凝剂(华法林与直接口服抗凝剂)满意度和便利性的看法
Patient Prefer Adherence. 2020 Oct 13;14:1911-1922. doi: 10.2147/PPA.S279621. eCollection 2020.
3
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
4
Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study).患者对预防中风的抗凝治疗的认知(共鸣研究)。
Open Heart. 2020 Mar 24;7(1):e001202. doi: 10.1136/openhrt-2019-001202. eCollection 2020.
5
Comparing quality of life and treatment satisfaction between patients on warfarin and direct oral anticoagulants: a cross-sectional study.比较服用华法林和直接口服抗凝剂患者的生活质量和治疗满意度:一项横断面研究。
Patient Prefer Adherence. 2019 Aug 14;13:1363-1373. doi: 10.2147/PPA.S204246. eCollection 2019.
6
Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.老年人房颤患者的生理、认知和心理社会状况与抗凝满意度的关系:SAGE-AF 研究。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2508-2515. doi: 10.1111/jce.14176. Epub 2019 Sep 25.
7
Treatment Expectations, Convenience, and Satisfaction with Anticoagulant Treatment: Perceptions of Patients in South-East Queensland, Australia.抗凝治疗的治疗期望、便利性及满意度:澳大利亚昆士兰州东南部患者的认知
J Clin Med. 2019 Jun 17;8(6):863. doi: 10.3390/jcm8060863.
8
Psychometric evaluation of the Polish version of the Arrhythmia‑Specific Questionnaire in Tachycardia and Arrhythmia: a new tool for symptom and health‑related quality of life assessment.波兰文版心动过速和心律失常特异性问卷的心理计量学评估:一种用于症状和健康相关生活质量评估的新工具。
Kardiol Pol. 2019 May 24;77(5):541-552. doi: 10.5603/KP.a2019.0046. Epub 2019 Mar 11.
9
Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis.非瓣膜性心房颤动患者口服抗凝治疗的优先事项:多准则决策分析。
Am J Cardiovasc Drugs. 2018 Dec;18(6):493-502. doi: 10.1007/s40256-018-0293-0.
10
Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation.接受口服抗凝剂治疗心房颤动患者的生活质量、治疗满意度及依从性的真实生活体验。
Patient Prefer Adherence. 2018 Jan 4;12:79-87. doi: 10.2147/PPA.S131158. eCollection 2018.

衰弱综合征和痴呆对老年房颤患者口服抗凝治疗便利性和满意度的影响。

The Influence of Frailty Syndrome and Dementia on the Convenience and Satisfaction with Oral Anticoagulation Treatment in Elderly Patients with Atrial Fibrillation.

机构信息

Department of Clinical Nursing, Medical University, 51-618 Wroclaw, Poland.

Department of Cardiology, T. Marciniak Hospital, 54-049 Wroclaw, Poland.

出版信息

Int J Environ Res Public Health. 2022 Apr 28;19(9):5355. doi: 10.3390/ijerph19095355.

DOI:10.3390/ijerph19095355
PMID:35564748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101389/
Abstract

Background: The impact of frailty syndrome (FS) and dementia on the convenience and satisfaction with oral anticoagulation (OAC) treatment in atrial fibrillation (AF) patients is not well-known. Aim: Assessment the impact of FS and dementia on the convenience and satisfaction with OAC treatment in 116 elderly (mean age 75.2, SD = 8.2) patients with AF. Methodology: A self-administered questionnaire was used in the study to collect basic socio-demographic and clinical data. Tilburg Frailty Indicator (TFI) questionnaire was used to assess the presence of FS, Mini Mental State Examination (MMSE) to assess cognitive impairment (CI), The Perception of Anticoagulant Treatment Questionnaire Part 2 (PACT-Q2) to assess convenience and satisfaction with OAC treatment, and the Arrhythmia-Specific Questionnaire in Tachycardia and Arrhythmia (ASTA) to assess quality of life (QoL). Results: Multivariable analysis as a significant, negative predictor of the convenience and satisfaction domain showed the occurrence of dementia (β = −0.34; p < 0.001, β = −0.41; p < 0.001, respectively) and prior major bleeding (β = −0.30; p < 0.001, β = −0.33; p < 0.001, respectively). Analysis showed a significant relationship between convenience and satisfaction and the overall result of the ASTA (r = −0.329; p < 0.001, r = −0.372; p < 0.001, respectively). Conclusions: Elements of geriatric syndrome, such as FS and dementia, adversely affect treatment convenience and satisfaction with OAC treatment in AF. It has been shown that better convenience and satisfaction with OAC treatment translates into better QoL. There were no differences between satisfaction and convenience and the type of OAC treatment (vitamin K antagonists (VKA) vs. novel oral anticoagulants (NOAC).

摘要

背景

衰弱综合征(FS)和痴呆症对房颤(AF)患者口服抗凝治疗(OAC)的便利性和满意度的影响尚不清楚。目的:评估 FS 和痴呆症对 116 名老年(平均年龄 75.2,SD=8.2)AF 患者 OAC 治疗的便利性和满意度的影响。方法:本研究采用自填式问卷收集基本社会人口学和临床数据。使用 Tilburg 衰弱指标(TFI)问卷评估 FS 的存在,使用简易精神状态检查(MMSE)评估认知障碍(CI),使用抗凝治疗感知问卷第二部分(PACT-Q2)评估 OAC 治疗的便利性和满意度,以及心律失常特异性心动过速和心律失常问卷(ASTA)评估生活质量(QoL)。结果:多变量分析作为便利性和满意度领域的显著负预测因素,显示痴呆症(β=-0.34;p<0.001,β=-0.41;p<0.001)和既往大出血(β=-0.30;p<0.001,β=-0.33;p<0.001)的发生。分析显示便利性和满意度与 ASTA 的总体结果呈显著相关(r=-0.329;p<0.001,r=-0.372;p<0.001)。结论:老年综合征的要素,如 FS 和痴呆症,会对 AF 患者的 OAC 治疗便利性和满意度产生不利影响。已经表明,更好的 OAC 治疗便利性和满意度会转化为更好的生活质量。在 OAC 治疗类型(维生素 K 拮抗剂(VKA)与新型口服抗凝剂(NOAC))之间,满意度和便利性没有差异。